Bruce Polsky, a director at Atea Pharmaceuticals, Inc., sells $168,095 of stock
After the sale, the filing lists 158,580 shares held. By the Insider Stock Trader: Alerts app. Information only, not investment advice.
A director at Atea Pharmaceuticals, Inc., Bruce Polsky, sold 41,226 shares of the company's stock on the open market between Nov 16 and Nov 18. The sale, at an average of $4.08 a share, comes to $168,095.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 158,580 shares held. No other open-market sale at Atea Pharmaceuticals, Inc. was reported in the previous 90 days.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Atea Pharmaceuticals, Inc. (AVIR) |
|---|---|
| Insider | Bruce Polsky |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 41,226 |
| Average price | $4.08 |
| Value | $168,095 |
| Trade dates | Nov 16 to Nov 18, 2026 |
| Filed with the SEC | Nov 18, 2026, 8:59 PM ET |
| Shares held after | 158,580 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See the detailed report on this AVIR sale
See the latest cluster buys and sells · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.